Reports Q2 revenue $549.65M, consensus $522.41M. “Our execution has improved, and our margins expanded,” said Symbotic (SYM) Chairman and Chief Executive Officer Rick Cohen. “With stronger project execution and a compelling roadmap of product innovation, we remain well-positioned to deliver increasing value to our stakeholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYM:
- Symbiotic options imply 14.5% move in share price post-earnings
- Symbotic price target lowered to $29 from $37 at Citi
- Symbotic price target lowered to $18 from $25 at Goldman Sachs
- Symbiotic call volume above normal and directionally bullish
- Symbotic’s Expansion Stagnation and Legal Challenges Signal Potential Stock Decline